Laura R. Byerly, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1151 N. Adair St., Cornelius, OR 97113 Phone: 503-359-5564 |
Lyn C Jacobs, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1151 N. Adair St., Cornelius, OR 97113 Phone: 503-359-5564 |
Barbara Trott, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 85 N 12th Ave, Cornelius, OR 97113 Phone: 503-359-5564 |
Teresa Erin Bair, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1151 N Adair St, Cornelius, OR 97113 Phone: 503-359-5564 Fax: 503-357-4371 |
Dr. Chelsea M Mcguire, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1151 N Adair St, Cornelius, OR 97113 Phone: 503-359-5564 Fax: 503-357-4371 |
Dr. Melissa Arguello-belli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1151 N Adair St, Cornelius, OR 97113 Phone: 503-359-5564 Fax: 503-357-4371 |
News Archive
Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.
Researchers at the University of California, Irvine have identified a key neural pathway in humans that explains how the brain processes feelings of fear and anxiety, a finding that could help scientists unlock new ways to treat mental health disorders.
Giving patients steroids at the time of heart surgery does not improve health outcomes and appears to put them at greater risk of having a heart attack in the days following surgery, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
A McKnight Foundation grant recently awarded to Compatible Technology International (CTI), Tanzania's Sokoine University of Agriculture (SUA) and the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) will address these needs. The organizations are combining their expertise for a four-year $673,000 research and development grant project, which will focus on enhancing child nutrition and the livelihoods of rural households in Malawi and Tanzania.
The U.S. Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease, a chronic inflammatory disease of the intestines, which affects an estimated one million Americans.
› Verified 2 days ago